# CM/PHR/23/5701- NHS National Framework for Natalizumab-February 2024

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Sandoz Ltd
- Award value: £63,746,000
- Tender value: £63,746,000
- Award date: 5 January 2024
- Published: 2 February 2024
- Contract start: 1 February 2024
- Contract end: 31 August 2025
- Stage: awarded
- Procurement category: goods
- Notice ID: 53f7b78e-75ed-4e96-b6cf-6d9ed4467538-719822
- OCID: ocds-b5fd17-af113a3d-7ddb-4c04-91a1-93583069c43a

## Description

NHS National Framework for Natalizumab - February 2024 Offer reference number: CM/PHR/23/5701 Period of framework: 1 February 2024 to 31 August 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\.

## Related contract awards

- [Modernising Education in TEL \(METEL\)](/contracts/ocds-b5fd17-f813e1f0-8dd4-4119-ba64-a1107d65501a): NHS England
- [NHS Online](/contracts/ocds-b5fd17-c65a69a7-ee33-4b4e-af0e-60156636c859): NHS England
- [CQC Well Led Financial Governance Assessor 26\_27](/contracts/ocds-b5fd17-0fc6347f-43a7-4f91-8b00-7372439b5969): NHS England
- [Dynamic Purchasing System \(DPS\) for the Supply of Antibiotics and IV Fluids \(Quarterly Notice\)](/contracts/ocds-b5fd17-9cd3e937-a9e3-448d-bdec-3f9a5b90f087): Department of Health and Social Care \(DHSC\)
- [NHS Midland & East Branded Medicines, Tranche B & Annual Tranche](/contracts/ocds-b5fd17-9a77eff1-de9e-4e91-9613-3cf1cd874bb6): NHS England
- [NHS National Generic Pharmaceuticals Wave 14a](/contracts/ocds-b5fd17-6e19d30d-423d-4c0d-9490-3367cb99ed30): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/53f7b78e-75ed-4e96-b6cf-6d9ed4467538-719822)